Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers look for ’silenced’ genes to monitor kidney cancer patients

19.04.2005


Researchers at Fox Chase Cancer Center in Philadelphia say looking for genes that have been turned off by cancer cells may become a reliable and noninvasive way to detect and monitor cancer in the kidney. The data were presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif.



Tumor-suppressor genes are part of the body’s natural defense against cancer. When inactivated--or "silenced"--they can no longer do their job, allowing cancer cells to grow. Cancer cells use a mechanism called hypermethylation to turn off the tumor-suppressor genes. "Finding these ’silenced’ genes is a good way to find cancer," said Essel A. Dulaimi, M.D., a postdoctoral fellow at Fox Chase. "Abnormal patterns of methylation can be detected in many cancers, including kidney cancer," she added. Early diagnosis of kidney cancer can lead to earlier treatment with a curative outcome.

Dulaimi and fellow Fox Chase researchers used a molecular DNA-based test to determine the presence or absence of methylation in a particular gene. Called methylation-specific polymerase chain reaction (PCR), the test can find one methylated gene among 100 unmethylated alleles (genes at the same site on a specific chromosome).


"This specificity is enough to detect even a few cancer cells among healthy cells," explained molecular biologist Paul Cairns, Ph.D., lead researcher of the study.

In an earlier Fox Chase study with six methylated genes (Cancer Research, Dec. 15, 2003), Dulaimi, Cairns, urologic surgical oncologist Robert G. Uzzo, M.D., and colleagues found an identical pattern of hypermethylation in both kidney tumors and urine collected before surgery. Forty-four of 50 urine samples (88 percent specificity) had a methylation pattern identical to the original tumor; all of the healthy patients showed no methylation (100 percent specificity).

"A gene that was postive for methylation in the urine was always positive in the matched tumor, " explained Cairns. "This is important because the DNA can be studied in the urine samples of patients who are being followed up after kidney surgery."

Thus, the methylation-specific test is a useful noninvasive tool. Until now, renal cancer could only be identified by a pathologist reviewing tumor tissue. In the study presented today at AACR, the researchers tested samples from 25 patients aged 33 to 73 who had undergone surgery to remove cancerous tumors confined to the kidney. At follow-up after surgery, none of the 25 patients had clinical evidence of disease.

The researchers hypothesized that these patients--who earlier had methylated tumors but now had no clinical evidence of disease--would have a follow-up urine sample that would show no methylation. This would confirm that they were, in fact, clinically disease-free.

The results showed that two patients had the same methylated gene in their urine samples that was methylated in the tumor. The other 23 patients had unmethylated genes in their urine samples.

"This means that we can monitor the presence of cancer by checking DNA in the urine periodically and looking for hypermethylation," said Uzzo.

"Our studies have proved that looking for hypermethylation in specific tumor-suppressor genes is useful for finding kidney cancer," Cairns said. "Now, it can also be applied to clinical follow up for patients with renal cancer."

Colleen Kirsch | EurekAlert!
Further information:
http://www.fccc.edu

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
18.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>